Nanocarriers are rapidly growing towards modifying several restrictions of conventional drug delivery systems for cancer therapy (
12,
16). Peptide transporters are among the most well-known nano-drug delivery systems, which firstly was described in the 1988s and later became known as CPPs (
1). CPPs offer exciting potential for effective delivery of biological molecules to the cytoplasm, which is otherwise impermeable to the cell membrane (
30). However, their unwanted cytotoxic effects can limit clinical exposure to these nanocarriers. This study was performed to evaluate the cytotoxic and immunogenic behavior of several synthetic CPPs on the CPP-mediated transfer of MTX
in-vitro.
Even though CPPs are presented as short sequences with no significant effect on the biological system, numerous studies have been done examining the biological impacts of various CPPs, including cationic and amphipathic ones (
21). Amongst which, amphipathic sequences have demonstrated more toxicity on cell metabolism compared to cationic ones. For instance, as an amphipathic peptide, TP10 was found to affect cellular metabolism more than cationic Penetratin, and TAT (
31). However, it has been shown that TP10 and its chemically modified derivatives induced no significant cytotoxicity and immunotoxicity at the concentrations of 10 μM and 5 μM
in-vitro and 5 mg/kg of animal
in-vivo (
32). In previous reports, several amphipathic peptides were successfully applied to traverse the cell membrane with no significant cytotoxicity (
1,
33). There have been other reports on the cytotoxic impacts of amphipathic peptides that proposed novel synthetic peptides as novel drug carriers for chemotherapeutics with the least cytotoxicity
in-vitro. According to another study, there was a time- and dose-dependent toxicity with synthetic amphipathic peptides comprising tryptophan and arginine residues (
34). Another group examined the
in-vitro immunotoxicity of HIV-TAT, antennapedia, and transportan in A549 (alveolar), A431 (epidermal), and Caco-2 (intestinal) epithelial cells after 72 h. Consequently, there was no significant enhancement detected in inducing inflammatory cytokines in epithelial cells, indicating that these commonly used CPPs are passive carriers (
34). Similarly, a cationic polyarginine peptide and penetration, at the dose of 1000 equivalent to their IC
50, exhibited no toxic effect. However, it has been reported that TAT peptide could affect cell metabolism and cause some mild swelling in the rabbit’s cornea after 7 days (
14,
31 and
32). Although the recent cytotoxic and immunogenic evaluations of different peptide sequences have been indicated no significant cell metabolism induction and biological responses, comprehensive investigations yet to be carried out. On the other hand, several advanced technologies such as nano-vectors (polymeric and liposomal), electroporation, genomics, and proteomics have been applied to overcome the challenges associated with cancer treatments (
34,
35). Furthermore, the application of CPPs to achieve an efficient delivery system is critical in the field of chemotherapy. MTX is a folate antagonist that has been used for the treatment of various malignancies (
36). The dose-dependent side effects of standard chemotherapeutics like MTX made them unsuitable for long-term therapies. It is essential to explore the potential applications of CPPs to deliver the therapeutic dosage of drugs to the cytoplasm of desired cells. The present study has addressed a significant safety concern regarding the application of CPPs for the efficient delivery of these drugs. In the present study, we evaluated the possible cytotoxic and immunogenic behavior of a new range of novel peptide sequences and their drug conjugates to elicit their possible role in the triggering of immune subsets or biological responses. Putting all together, we did not observe any significant cell viability reduction in Raji cells treated with each type of CPPs, as well as no activation of cytokine release after 48 h incubation with selected CPPs and peptide-MTX conjugates. Up to 50 μM, peptides illustrated no cytotoxic effect on Raji cells, while there was an exception for [WR]
4 at 5µM after 24 h (
Figure 3). Moreover, the conjugation of NGRWK, R
6, and [WR]
4 with MTX presented intensive cytotoxicity by reducing the cell viability down to 40%. Therefore, we removed cytotoxic peptide-MTX conjugates in the further immunogenic assessment. None of the measured cytokines (IL-
6 or TNF-
α) were overexpressed in the Raji cells after incubation with selected CPPs, peptide-MTX conjugates, or nanoparticles. Meanwhile, as expected, cells incubated with LPS as positive control illustrated cytokine level enhancement 100-times higher than the control group (
Figure 5).